GlassScriptPhysician profile
Roman Ivankiv
NPI 1528517331
$5,598.57
in general payments reported to CMS, 2019-2025
23 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $242 · 2021: $1,768 · 2022: $749 · 2023: $1,293 · 2024: $589 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561 · Travel and Lodging: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,561.40 |
| Travel and Lodging | $833.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,715.19 | 2020-2023 | Prostep, Ortholoc 2 Lapifuse, Prophecy |
| Smith+Nephew, INC. | $1,012.31 | 2021-2024 | Grafix, Stravix Pl, Oasis |
| Organogenesis INC. | $626.73 | 2019-2023 | Puraply |
| Arthrex, INC. | $484.90 | 2025 | |
| Horizon Therapeutics Plc | $397.15 | 2019-2023 | Krystexxa |
| Cardiovascular Systems INC. | $172.03 | 2022 | |
| Kerecis Limited | $160.52 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $147.73 | 2024 | Hammertube Sterile Implant Kits |
| Bard Peripheral Vascular, INC. | $133.77 | 2024 | Venclose Maven Catheter |
| Penumbra, INC. | $120.82 | 2024 | Penumbra System |
| Paratek Pharmaceuticals, INC. | $120.40 | 2022 | |
| Tactile Systems Technology INC | $98.09 | 2019 | |
| Abbott Laboratories | $97.96 | 2023 | Diamondback Peripheral |
| Musculoskeletal Transplant Foundation INC. | $73.48 | 2021 | |
| Next Science LLC | $47.81 | 2023 | Surgx, Xperience, Blastx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $38.54 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $28.09 | 2019-2022 | |
| Kci USA, INC. | $27.80 | 2023 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Solventum Corporation | $27.73 | 2025 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
| Pacira Pharmaceuticals Incorporated | $20.66 | 2022 | |
| Acera Surgical, INC. | $18.80 | 2022 | |
| Nabriva Therapeutics, Plc | $17.22 | 2022 | |
| Embody, INC. | $10.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Ivankiv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.